| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 716344 | Null | 0.0208632511155816 | 0.46929773 |
| NSC 732851 | 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene | 0.0208632511155816 | 0.32387868 |
| NSC 736164 | pyrazoline derivative | 0.0208632511155816 | 0.45617064 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0208632511155816 | 0.5532206 |
| NSC 741942 | Null | 0.0208632511155816 | 0.32965345 |
| NSC 742327 | (3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone | 0.0208632511155816 | 0.22922814 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0208632511155816 | 0.21150317 |
| NSC 96996 | B 169 | 0.0208632511155816 | 0.33079697 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0208632511155817 | 0.3430275 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0208632511155817 | 0.32443278 |